These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12580871)

  • 1. Developments in radiotherapy and adjuvant chemotherapy for head and neck cancer.
    Glaholm J; Watkinson JC
    Clin Otolaryngol Allied Sci; 2003 Feb; 28(1):1-4. PubMed ID: 12580871
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ; Moini M; Giuliano J; Westra WH
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The end of the hypoxic EPOch.
    Aguilera TA; Giaccia AJ
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):895-7. PubMed ID: 25832683
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiochemotherapy in head and neck cancer.
    Merlano M; Marchetti G
    Cancer Treat Rev; 2003 Aug; 29(4):291-6. PubMed ID: 12927569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: based on RTOG trial #79-15.
    Fazekas JT; Scott C; Marcial V; Davis LW; Wasserman T; Cooper JS
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1177-81. PubMed ID: 2689395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiation in the treatment of head and neck cancer.
    Haffty BG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):719-42, vi-vii. PubMed ID: 10494509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical science and patient care: lessons from cooperative randomized clinical trials.
    Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):273-4. PubMed ID: 9308927
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity.
    Henk JM
    Clin Oncol (R Coll Radiol); 1997; 9(5):308-12. PubMed ID: 9368726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
    Rischin D; Peters L; Hicks R; Hughes P; Fisher R; Hart R; Sexton M; D'Costa I; von Roemeling R
    J Clin Oncol; 2001 Jan; 19(2):535-42. PubMed ID: 11208848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer.
    Stadler P; Feldmann HJ; Creighton C; Kau R; Molls M
    Radiother Oncol; 1998 Aug; 48(2):157-64. PubMed ID: 9783887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts].
    Calais G; Le Floch O
    Bull Cancer Radiother; 1996; 83(4):321-9. PubMed ID: 9081334
    [No Abstract]   [Full Text] [Related]  

  • 12. Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer.
    Freedman LS; Honess DJ; Bleehen NM; Adams GE; Dische S; Henk JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Dec; 52(6):965-7. PubMed ID: 3500934
    [No Abstract]   [Full Text] [Related]  

  • 13. Combining radiotherapy with systemic therapies.
    Vokes EE
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.
    Fazekas J; Pajak TF; Wasserman T; Marcial V; Davis L; Kramer S; Rotman M; Stetz J
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1155-60. PubMed ID: 3301758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of head and neck cancer.
    LaFollette S; Taylor SG
    Cancer Chemother Biol Response Modif; 1996; 16():462-73. PubMed ID: 8639394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant treatment of head and neck cancers: advances and challenges].
    Bernier J
    Bull Cancer; 2007 Sep; 94(9):823-7. PubMed ID: 17878103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality therapy of head and neck cancer.
    Stupp R; Weichselbaum RR; Vokes EE
    Semin Oncol; 1994 Jun; 21(3):349-58. PubMed ID: 8209266
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxic cell radiosensitizers: the end of an era? Regarding Lee et al., IJROBP 32:567-576; 1995.
    Brown JM
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):883-5. PubMed ID: 7790276
    [No Abstract]   [Full Text] [Related]  

  • 19. Redefining the role of induction chemotherapy in head and neck cancer.
    Adelstein DJ
    J Clin Oncol; 2008 Jul; 26(19):3117-9. PubMed ID: 18474875
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.